05.12.21 -- Partners Ready To Support Your Post-Approval Studies
As an established leader with decades of experience in Real-World Evidence (RWE) generation – UBC offers clients a distinct advantage as they move their specialty product from clinical development to the market.
When patients are waiting for life-altering treatments, every milestone is critical, Precision applies demonstrated expertise from quantifying the burden of disease for narrow patients populations to demonstrating and communicating the economic and clinical value of cell and gene therapies, traversing the commercialization landscapes to improve or save patient lives.
The increase in volume, complexity, and variety of healthcare data sources leads to viable, but unstructured, data. Cytel applies advanced analytics to turn that disorganized data into evidence.